Lonnel Coats, Director at Blueprint Medicines Corp (BPMC), sold 34,935 shares at $94.87 ($3.3M) on 2024-11-21, disclosed to the SEC on 2024-11-22.
Scheduled sale ($3.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $93.15 | 4,500 | $419K | 12.7% |
| 2 | $94.24 | 5,287 | $498K | 15.1% |
| 3 | $94.24 | 5,287 | $498K | 15.1% |
| 4 | $94.99 | 213 | $20K | 0.6% |
| 5 | $94.87 | 9,824 | $932K | 28.2% |
| 6 | $94.87 | 9,824 |
| $932K |
| 28.2% |
| Total | $94.46 avg | 34,935 | $3.3M | 100% |
| Filing → |
| LXRX | BUY | 2023-06-29 | $22K | — | Filing → |
| LXRX | BUY | 2023-06-26 | $47K | — | Filing → |
| LXRX | BUY | 2023-06-22 | $92K | — | Filing → |